scispace - formally typeset
Open AccessJournal ArticleDOI

Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond

Reads0
Chats0
TLDR
The ways in which S1P might be therapeutically targeted are discussed — for example, via the development of chemical inhibitors that target the generation, transport and degradation of S 1P and via thedevelopment of specific S1p receptor agonists.
Abstract
The bioactive lipid sphingosine-1-phosphate (S1P) is involved in multiple cellular signalling systems and has a pivotal role in the control of immune cell trafficking. As such, S1P has been implicated in disorders such as cancer and inflammatory diseases. This Review discusses the ways in which S1P might be therapeutically targeted — for example, via the development of chemical inhibitors that target the generation, transport and degradation of S1P and via the development of specific S1P receptor agonists. We also highlight recent conflicting results observed in preclinical studies targeting S1P and discuss ongoing clinical trials in this field.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Sphingosine-1-Phosphate (S1P) Impacts Presynaptic Functions by Regulating Synapsin I Localization in the Presynaptic Compartment

TL;DR: Evidence is provided that S1P can be produced at mature axon terminals as well as at immature growth cones in response to microglia-derived signals, which may be important to stabilize nascent synapses and to restore or potentiate transmission.
Journal ArticleDOI

Breast cancer sphingosine-1-phosphate is associated with phospho-sphingosine kinase 1 and lymphatic metastasis

TL;DR: This is the first study to demonstrate that high expression of pSphK1 is associated with higher levels of S1P, which in turn isassociated with lymphatic metastasis in breast cancer.
Journal ArticleDOI

Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration

TL;DR: The concept that PP2A also constrains inflammatory responses through its inhibitory effects on various signalling pathways is explored, suggesting that PADs may be effective in the treatment of inflammation-mediated pathologies.
Journal ArticleDOI

Quantification of sphingosine 1-phosphate by validated LC-MS/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation

TL;DR: It is found that the methanol precipitation used to extract S1P co-extracted apoM and several other HDL-proteins from plasma, thus increasing the S 1P concentration to double in serum as compared to that in plasma.
Journal ArticleDOI

Macrophage-Bacteria Interactions-A Lipid-Centric Relationship.

TL;DR: The emerging roles of lipids in the complex host–pathogen relationship are reviewed and recent methodologies employed to probe these versatile metabolites during the infection process are discussed.
References
More filters
Journal ArticleDOI

STATs in cancer inflammation and immunity: a leading role for STAT3

TL;DR: Signal transducer and activator of transcription proteins are central in determining whether immune responses in the tumour microenvironment promote or inhibit cancer, and STAT3 is a promising target to redirect inflammation for cancer therapy.
Journal ArticleDOI

Principles of bioactive lipid signalling: lessons from sphingolipids

TL;DR: An understanding of the complex pathways of sphingolipid metabolism and the mechanisms that regulate lipid generation and lipid action is required to understand the mechanisms of cell growth, death, senescence, adhesion, migration, inflammation, angiogenesis and intracellular trafficking.
Journal ArticleDOI

The many roles of histone deacetylases in development and physiology: Implications for disease and therapy

TL;DR: In this article, the expression of many HDAC isoforms in eukaryotic cells raises questions about their possible specificity or redundancy, and whether they control global or specific programs of gene expression.
Journal Article

Heart-lung transplantation.

TL;DR: A broad overview of the various grounds upon which this difference is likely based and discuss recent advances in each area: 1) criteria for the selection of candidates and donors, 2) methods for ex-vivo preservation of donor organs, 3) technical execution of the operative procedure, and 4) prevention of postoperative infection as discussed by the authors.
Journal ArticleDOI

Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase

TL;DR: The identification of a small molecule called necrosulfonamide that specifically blocks necrosis downstream of RIP3 activation is reported, which implicate MLKL as a key mediator of necrosis signaling downstream of the kinase RIP3.
Related Papers (5)